Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the CEPHEUS, IMROZ, and BENEFIT trials of treatment for transplant-ineligible ...

Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions ...